KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 148 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $66,000 | +17.9% | 12,012 | -2.7% | 0.00% | – |
Q2 2022 | $56,000 | -41.1% | 12,341 | -3.8% | 0.00% | – |
Q1 2022 | $95,000 | -11.2% | 12,833 | -23.1% | 0.00% | – |
Q4 2021 | $107,000 | +5.9% | 16,684 | -3.6% | 0.00% | – |
Q3 2021 | $101,000 | -56.5% | 17,314 | -22.9% | 0.00% | -100.0% |
Q2 2021 | $232,000 | +24.7% | 22,451 | +27.2% | 0.00% | 0.0% |
Q1 2021 | $186,000 | -33.3% | 17,651 | -2.0% | 0.00% | 0.0% |
Q4 2020 | $279,000 | -12.8% | 18,011 | -17.7% | 0.00% | 0.0% |
Q3 2020 | $320,000 | +13.5% | 21,886 | +47.1% | 0.00% | 0.0% |
Q2 2020 | $282,000 | +19.5% | 14,881 | +21.0% | 0.00% | 0.0% |
Q1 2020 | $236,000 | – | 12,295 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |